Prions are slow infectious pathogens which cause several transmissible, degenerative neurological disorders, including scrapie of sheep and goats as well as Creutzfeldt-Jakob disease (CJD), kuru, and Gerstmann Straussler syndrome of humans (16, 25, 32) . Prions are unusual in that they display extreme resistance to inactivation by procedures which inactivate nucleic acids (5, 6, 32) .
The precise molecular composition of prions has remained elusive. All attempts to identify a scrapie-specific nucleic acid have been unsuccessful (5, 6, 29) . To date, only a single macromolecule has been shown to be required for infectivity; this macromolecule in hamsters is a protease-resistant sialoglycoprotein designated PrP 27-30 (26) , for prion protein of Mr 27 to 30 kilodaltons (kDa). PrP 27-30 purifies with and is inseparable from scrapie infectivity (10, 11, 26, 33, 35, 36) . Additionally, proteolytic digestion of PrP 27-30 proceeds with kinetics identical to proteolytic inactivation of prions (26) . Recent studies show that PrP 27-30 is formed during purification from a larger protein in hamsters of 33 to 35 kDa and that normal, uninfected hamsters contain a related, protease-sensitive protein of 33 to 35 kDa (3, 29) . Studies of scrapie in mice revealed similar protease-resistant proteins of similar molecular masses (11, 18) . We designate the mouse scrapie prion proteins MoPrPsc and the cellular isoform MoPrPC.
Presently most studies involving prions are conducted in experimental models of scrapie in rodents. Although these systems have proven advantageous because of their comparatively short incubation period for prions, they are not optimal for detailed molecular analyses. Hence, several groups have attempted to develop cell cultures for scrapie infection and prion replication. In one attempt, mouse L cells were infected with a scrapie mouse brain homogenate (13, 14) ; however, these cells lost their infectivity with repeated passages. Since these cells were not cloned, it is * Corresponding author.
possible that much of the observed infectivity was carried over from the original inoculum. Other groups have reported successful replication of the infectious agent in neuronal models such as NlE 115, a mouse neuroblastoma line (24) , and PC12, a rat pheochromocytoma line (39) . In these studies, clonal infected lines were not established, necessitating reinfection for each infectivity study and thereby jeopardizing consistency from experiment to experiment. The investigation with PC12 cells was further complicated by infecting these rat cells with mouse scrapie prions and measuring the infectivity associated with the rat cells in mice. Crossing species barriers is associated with prolonging the incubation period (30, 31) . Species-specific epitopes have recently been demonstrated for prion proteins, reflecting their cellular origin (9, 29) .
Herein, we report experimental studies with clonal cell lines which are chronically infected with either mouse scrapie prions or mouse CJD prions. These lines are derived from the mouse neuroblastoma line N2a. The initial phase of this work involved the identification of murine N2a cells as a suitable host for infection with partially purified fractions derived from murine brains infected with CJD prions and the demonstration that infected clonal cell lines could be derived (D. T. Kingsbury Infection of N2a cells with mouse CJD prions. N2a cells were grown in minimal essential medium containing 10% fetal calf serum and gentamicin (100 ,ug/ml). Subconfluent monolayers in 25-cm2 flasks (-2.5 x 10' cells) were inoculated with a 1:10 dilution of the ammonium sulfate precipitate (-6.7 x 10' ID50 units) of murine CJD prions. Cells were subcultured 1:3 and then cloned into 96-well plates. Viable clones were subcultured 1:2, expanded into 24-well plates, subcultured 1:2, and then harvested at confluency. Groups of four wells were pooled, and the cell pellets were suspended in 150 mM NaCl. The suspensions were then subjected to three rounds of freeze-thawing. Supernatants from a low-speed centrifugation were inoculated intracerebrally into NAMRU mice. Passage and cloning of the cells would have resulted in each mouse receiving a maximum of l0-5 ID50 units of the original inoculum. Animals were observed for 1 year and scored positive for CJD by clinical symptoms. Diagnosis was verified histopathologically and by resistance of the agent to heat inactivation. Titers were determined by the incubation time assay as modified for CJD in NAMRU mice (42) .
Preparation of cell lysates for Western blotting. Two procedures were used to prepare cell lysates for analysis. In the first procedure, two confluent 175-cm2 flasks per sample were washed once with cold PBS, scraped into cold PBS, pelleted by centrifugation, and suspended in 5 ml of 320 mM sucrose. Cells were homogenized by four 5-s pulses with a polytron homogenizer. Homogenates were then cleared by centrifugation at 1,500 x g, 15 min, 4°C. The supernatants were centrifuged at 200,000 x g, 30 min, 4°C, in a 50 Ti rotor. The resulting pellets constituted enriched membrane fractions and were suspended in 20 mM Tris hydrochloride (pH 7.4)-150 mM NaCI-0.2% Sarkosyl (sodium dodecyl sarcosinate). Suspensions were split into two equal portions, and one was digested with proteinase K (5 ,ug/ml, 37°C, 30 min) and the other was left undigested. Phenylmethylsulfonyl fluoride was then added to a final concentration of 5 mM to all samples on ice. Proteins were precipitated by addition of 10% trichloroacetic acid on ice and centrifuged in a microfuge for 15 min. Pellets were washed four times with cold acetone and then suspended in 2x sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (62.5 mM Tris hydrochloride, pH 6.8, 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.002% bromophenol blue). Samples were boiled for 5 b The individual clones are characterized in Table 4 and Fig. 4. N (25) .
PrP synthetic peptides and antisera. Rabbit polyclonal antisera (R003 and R017) were raised against PrP 27-30 purified from scrapie-infected hamster brain (2, 7). Peptide antigens were synthesized on an Applied Biosystems (Foster City, Calif.) 430A peptide synthesizer (19) . The amino acid sequences of the PrP peptides are as follows, with some residue numbers (4) shown: P3, Cys-Gly-Gly-Lys-220-GluSer-Gln-Ala-Tyr-Tyr-Asp-Gly-Arg-Arg-Ser-Ser-Ala-233; P5, Cys-Gly-Gly-Gly-142-Asn-Asp-Trp-Glu-Asp-Arg-Tyr-TyrArg-Glu-Asn-Met-Asn-Arg-Tyr-Pro-Asn-Gln-Asn-Asn-174. The glycine and cysteine residues shown in italics were added to facilitate coupling of the synthetic peptide P3 to carrier proteins as described previously (1) .
Immunoblotting. Immunoblotting was performed essentially as described before (29) . Rabbit PrP 27-30 antisera (R003 and R017) were diluted 1:500, 1:750, or 1:1,000; synthetic peptide P3 antiserum was diluted 1:1,000. Goat anti-rabbit immunoglobulin sera coupled to alkaline phosphatase was obtained from Promega and diluted 1:7,500. Electrotransfer of protein from SDS-polyacrylamide gels to nitrocellulose was accomplished with standard buffers containing either 0.01 or 0.05% (wt/vol) SDS. (Table 1) . Throughout the experiment, the cells were examined by phase-contrast microscopy. No cytopathology was observed which could be unambiguously attributed to prion infection.
RESULTS

Replication
As shown in Table 1 , only the N2a cells which had been infected at an MOI of 100 were infective. The average incubation period for mice inoculated with this sample was 154 days (Fig. 1) . Passaging and subcloning the cells resulted in a dilution of the original inoculum by at least a factor of 109. At the highest MOI (100), a dilution of 109 would result in a titer of 0.02 ID50 U/107 cells if the infectivity was simply due to the presence of the original inoculum. In the infectious sample, we detected a titer of i104 ID50 U/107 cells (Fig. 1) used Western blotting analysis to determine whether we could detect MoPrPSc in any of the five clones which composed the infectious inoculum (Table 1) . Normal mouse brain contains PrPC, but no proteinase K-resistant proteins were detected by immunoblotting (Fig. 2, lanes 1 and 2) . PrPC was not readily detected in extracts of uninfected N2a cells, and no immunostaining was seen after limited proteinase K digestion (Fig. 2, lanes 3 and 4) . PrPSc was also not readily detectable in infected N2a cells by immunostaining prior to purification. Digesting detergent extracts of infected cells with proteinase K provided the purification needed for PrPSc detection on Western blotting (Fig. 2, lanes 7 and 8) . The apparent molecular masses of these proteinase Kresistant proteins were between 20 and 30 kDa, as determined by SDS-PAGE. These proteins were absent from the uninfected N2a cells (Fig. 2, lane 4) . The PrP-immunoreactive proteins aligned well with the proteinase K-resistant proteins from a scrapie mouse brain homogenate (Fig. 2,  lanes 6 and 8) . We detected MoPrPSC in this cell line by preparation of membrane fractions, by lysis of the cells with a variety of detergents, and with two different polyclonal PrP 27-30 antisera. The production of MoPrPSc in this clone was stable for at least 30 passages.
The authenticity of the proteinase K-resistant, PrP-immunoreactive proteins in scrapie-infected N2a cells was established by using monospecific rabbit antisera raised against a synthetic peptide (P3) corresponding to amino acid residues 220 to 233 of hamster PrP (4). The corresponding sequence in mouse is identical except for the first and last residues (23, 43) . As shown in Fig. 3 , the preimmune serum failed to react with MoPrPSC, while the immune serum strongly bound to the protein (lanes 1 and 2) . Immunostaining was abolished by absorbing the antisera with the peptide P3 (lanes 3 and 4), while absorption with an unrelated synthetic peptide corresponding to hamster PrP residues 142 to 174 did not alter immunostaining (lane 5). The Western blot pattern of scrapie-infected N2a cells with synthetic peptide antisera was identical to that observed with polyclonal rabbit antisera raised against purified hamster PrP 27-30 (lane 6). Likewise, the PrPSC immunoblots from scrapie N2a cells were almost indistinguishable from those obtained with scrapie-infected brain with either the synthetic PrP peptide antiserum (Fig. 3,  lanes 2 and 7) or the polyclonal PrP 27-30 antiserum (Fig. 2) .
Infected cells produce MoPrPsc. To determine whether the clone 3, which produced MoPrPSc, was infectious by itself, . . . . . . . . . S , , , . , e , . j . we bioassayed each of the clones separately. Our results indicate that the clone which produced MoPrPSc as shown by Western blotting was indeed infectious by itself and was the only one of the original five clones ( Table 1 ) that was infectious (Table 4) . To assess whether we could detect secretion of prions from the cells, the medium in which each clone had been grown overnight was collected and bioassayed. We found trace infectivity in the medium of clone 3 which may have resulted from the release of prions by cell lysis. The lack of appreciable infectivity in the medium suggests that the scrapie-infected N2a cells were not actively secreting prions. It is possible, though, that higher titers 1 2 3 4 56 7 performed on clones 1 to 5 prior to bioassays. b Titers were determined by using the calibration curve shown in Fig. 1 .
The experiment was terminated 266 days after inoculation of the mice.
might be found in the medium if the medium was harvested after a longer period of time.
In Fig. 4 prions. These cell lines were isolated and subcloned from a population of mouse neuroblastoma (N2a) cells which were infected with either a sucrose gradient preparation of mouse scrapie prions or an ammonium sulfate precipitate of mouse CJD prions.
We found that the scrapie-infected cell line produced three major protease-resistant, PrP-immunoreactive prion proteins with apparent molecular masses ranging between 20 and 30 kDa. This correlation between scrapie infectivity and MoPrPSC extends earlier studies indicating that hamster PrP 27-30 is inseparable from scrapie infectivity (26) . The argument that PrPSC is an integral component of the infectious scrapie prion is now supported by seven distinct experimental observations: (i) and scrapie prions copurify; PrP 27-30 is the most abundant molecule in purified prion preparations (10, 36) Because of the problems with immunoblotting described above and the low titers of scrapie prions found in infected N2a cells, no attempt was made to correlate the concentration of PrPSc with the prion titer as was done previously for purified prions from hamster brain (26, 34) .
Factors governing the infectability of cultured cells by prions are unknown. From the results of animal studies (9, 30, 31), we presume that prions from the same species as the host-cultured cells will be most infectious. Crossing species in animal studies clearly results in prolongation of the incubation period. Molecular cloning studies show that -10% of amino acid residues vary among mouse, hamster, and human PrP sequences. Inbred strains of mice having short or long scrapie incubation periods possess prion proteins differing by two residues (43 Our discovery of PrPSc molecules in cultured cells harboring scrapie prion infectivity provides a readily detectable marker for future experimental studies. Cultured cells infected with scrapie prions should facilitate the structural analysis of PrPc and PrPSc molecules. The profound differences in the properties of these two molecules are thought to arise from a posttranslational event, since both PrP isoforms probably have the same amino acid sequence (4) . The use of radiolabeled precursors to investigate the posttrahslational modifications of the two PrP isoforms may prove plausible if isotope incorporation is sufficiently great; however, it is likely that much higher levels of PrPc and PrPSc in cell culture will be needed before many studies can be performed. Hopefully, cloned PrP genes inserted into expression vectors (M. Scott, D. Butler, D. Bredesen, M. Walchli, K. Hsiao, and S. B. Prusiner, Protein Eng., in press) will be useful in raising the levels of prion proteins in cultured cells.
